Abstract
Classical antibiotic discovery efforts have relied mainly on molecular library screening coupled with target-based lead optimization. The conventional approaches are unable to tackle the emergence of antibiotic resistance and are failing to provide understanding of multiple mechanisms behind drug actions and the off-target effects. These insufficiencies have prompted researchers to focus on a multidisciplinary approach of systems biology-based antibiotic discovery. Systems biology is capable of providing a big-picture view for therapeutic targets through interconnected networks of biochemical reactions derived from both experimental and computational techniques. In this chapter, we have compiled software tools and databases that are typically used for target identification through in silico analyses. We have also identified enzyme- and broad-spectrum metabolite-based drug targets that have emerged through in silico systems microbiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bevan P, Ryder H, Shaw I (1995) Identifying small-molecule lead compounds: the screening approach to drug discovery. Trends Biotechnol 13:115–121
Kitano H (2002) Systems biology: a brief overview. Science 295:1662–1664
Gwynn MN, Portnoy A, Rittenhouse SF et al (2010) Challenges of antibacterial discovery revisited. Ann N Y Acad Sci 1213:5–19
Westerhoff HV, Palsson BO (2004) The evolution of molecular biology into systems biology. Nat Biotechnol 22:1249–1252
Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259
Davidov E, Holland J, Marple E et al (2003) Advancing drug discovery through systems biology. Drug Discov Today 8:175–183
Aderem A (2005) Systems biology: its practice and challenges. Cell 121:511–513
Palsson B (2000) The challenges of in silico biology. Nat Biotechnol 18:1147–1150
Kitano H (2002) Computational systems biology. Nature 420:206–210
Raman K, Yeturu K, Chandra N (2008) TargetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2:109
Gu S, Chen J, Dobos KM et al (2003) Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol Cell Proteomics 2:1284–1296
Bahk YY, Kim SA, Kim JS et al (2004) Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker. Proteomics 4:3299–3307
Mawuenyega KG, Forst CV, Dobos KM et al (2005) Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol Biol Cell 16:396–404
Mattow J, Siejak F, Hagens K et al (2007) An improved strategy for selective and efficient enrichment of integral plasma membrane proteins of mycobacteria. Proteomics 7:1687–1701
Malen H, Berven FS, Fladmark KE et al (2007) Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7:1702–1718
Gonzalez-Zamorano M, Mendoza-Hernandez G, Xolalpa W et al (2009) Mycobacterium tuberculosis glycoproteomics based on ConA-lectin affinity capture of mannosylated proteins. J Proteome Res 8:721–733
Sarker M, Chopra S, Mortelmans K et al (2011) In silico pathway analysis predicts metabolites that are potential antimicrobial targets. J Comput Sci Syst Biol 4:021–026
Munger J, Bennett BD, Parikh A et al (2008) Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 26:1179–1186
Kim HU, Kim TY, Lee SY (2010) Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE. Mol Biosyst 6:339–348
Kim TY, Kim HU, Lee SY (2010) Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab Eng 12:105–111
Kim HU, Kim SY, Jeong H et al (2011) Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol 7:460
Schilling CH, Palsson BO (2000) Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J Theor Biol 203:249–283
Yeh I, Hanekamp T, Tsoka S et al (2004) Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res 14:917–924
Rahman SA, Schomburg D (2006) Observing local and global properties of metabolic pathways: ‘load points’ and ‘choke points’ in the metabolic networks. Bioinformatics 22:1767–1774
Jamshidi N, Palsson BO (2007) Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol 1:26
Chavali AK, Whittemore JD, Eddy JA et al (2008) Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol 4:177
Mazumdar V, Snitkin ES, Amar S et al (2009) Metabolic network model of a human oral pathogen. J Bacteriol 191:74–90
Oberhardt MA, Goldberg JB, Hogardt M et al (2010) Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J Bacteriol 192:5534–5548
Raghunathan A, Shin S, Daefler S (2010) Systems approach to investigating host-pathogen interactions in infections with the biothreat agent Francisella. Constraints-based model of Francisella tularensis. BMC Syst Biol 4:118
Crowther GJ, Shanmugam D, Carmona SJ et al (2010) Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis 4:e804
Plata G, Hsiao TL, Olszewski KL et al (2010) Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network. Mol Syst Biol 6:408
Navratil V, De Chassey B, Combe CR et al (2011) When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. BMC Syst Biol 5:13
Fatumo S, Plaimas K, Adebiyi E et al (2011) Comparing metabolic network models based on genomic and automatically inferred enzyme information from Plasmodium and its human host to define drug targets in silico. Infect Genet Evol 11:708–715
Fang K, Zhao H, Sun C et al (2011) Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction. BMC Syst Biol 5:83
Ng A, Bursteinas B, Gao Q et al (2006) Resources for integrative systems biology: from data through databases to networks and dynamic system models. Brief Bioinform 7:318–330
Jagarlapudi SA, Kishan KV (2009) Database systems for knowledge-based discovery. Methods Mol Biol 575:159–172
Ghosh S, Matsuoka Y, Asai Y et al (2011) Software for systems biology: from tools to integrated platforms. Nat Rev Genet 12:821–832
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sarker, M., Talcott, C., Galande, A.K. (2013). In Silico Systems Biology Approaches for the Identification of Antimicrobial Targets. In: Kortagere, S. (eds) In Silico Models for Drug Discovery. Methods in Molecular Biology, vol 993. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-342-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-62703-342-8_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-341-1
Online ISBN: 978-1-62703-342-8
eBook Packages: Springer Protocols